Pharmacokinetic evaluation of piperacillin-tazobactam

Y Hayashi, JA Roberts, DL Paterson… - Expert opinion on drug …, 2010 - Taylor & Francis
Importance of the field: Piperacillin-tazobactam is a frequently prescribed intravenous
antibiotic for moderate to severe infections used in hospital settings because of its broad …

A narrative review of predictors for β-lactam antibiotic exposure during empirical treatment in critically ill patients

A Abdulla, TMJ Ewoldt, IM Purmer… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction: Emerging studies suggest that antibiotic pharmacokinetics (PK) are difficult to
predict in critically ill patients. The high intra-and inter-patient PK variability makes it …

Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

JJ De Waele, J Lipman, M Akova, M Bassetti… - Intensive care …, 2014 - Springer
Purpose Risk factors for β-lactam antibiotic underdosing in critically ill patients have not
been described in large-scale studies. The objective of this study was to describe …

Breaking down the breakpoints: rationale for the 2022 Clinical and Laboratory Standards Institute revised piperacillin-tazobactam breakpoints against …

PD Tamma, PNA Harris, AJ Mathers… - Clinical Infectious …, 2023 - academic.oup.com
Piperacillin-tazobactam (PTZ) is one of the most common antibiotics administered to
hospitalized patients. Its broad activity against gram-negative, gram-positive, and anaerobic …

Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants

M Cohen-Wolkowiez, KM Watt, C Zhou… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Piperacillin-tazobactam is often given to infants with severe infection in spite of limited
pharmacokinetics (PK) data. We evaluated piperacillin-tazobactam PK in premature and …

Population pharmacokinetics and pharmacodynamics of extended-infusion piperacillin and tazobactam in critically ill children

K Nichols, EK Chung, CA Knoderer… - Antimicrobial agents …, 2016 - Am Soc Microbiol
The study objective was to evaluate the population pharmacokinetics and
pharmacodynamics of extended-infusion piperacillin-tazobactam in children hospitalized in …

Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients

EK Chung, SC Cheatham, MR Fleming… - The Journal of …, 2015 - Wiley Online Library
The study objective was to evaluate the population pharmacokinetics and
pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in …

In Vitro Pharmacodynamics of Various Antibiotics in Combination against Extensively Drug-Resistant Klebsiella pneumoniae

TP Lim, Y Cai, Y Hong, ECY Chan… - Antimicrobial Agents …, 2015 - Am Soc Microbiol
Extensively drug-resistant (XDR) Klebsiella pneumoniae is an emerging pathogen in
Singapore. With limited therapeutic options available, combination antibiotics may be the …

Setting antimicrobial susceptibility testing breakpoints: a primer for pediatric infectious diseases specialists on the Clinical and Laboratory Standards Institute …

VM Pierce, AJ Mathers - Journal of the Pediatric Infectious …, 2022 - academic.oup.com
Breakpoints are the values used by clinical microbiology laboratories to interpret the results
of antimicrobial susceptibility testing (AST) and classify isolates as susceptible or resistant …

Antimicrobial dosing in acute renal replacement

WH Fissell - Advances in chronic kidney disease, 2013 - Elsevier
Acute kidney injury (AKI) is a common problem in hospitalized patients and is associated
with significant morbidity and mortality. Two large trials showed no benefit from increased …